GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2014-12-30: Form 6-K; Period of report 2014-12-30; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201412306k.htm.
- 2014-12-18: Form 6-K; Period of report 2014-12-18; Description RESULT OF GENERAL MEETING; Document gsk201412186k2.htm.
- 2014-12-11: Form 6-K; Period of report 2014-12-11; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201412116k.htm.
- 2014-12-10: Form 6-K; Period of report 2014-12-10; Description DIRECTOR/PDMR SHAREHOLDING; Document gsk201412106k.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2014-12-30 | 6-K | 2014-12-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201412306k.htm |
| 2014-12-18 | 6-K | 2014-12-18 | RESULT OF GENERAL MEETING | gsk201412186k2.htm |
| 2014-12-11 | 6-K | 2014-12-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201412116k.htm |
| 2014-12-10 | 6-K | 2014-12-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201412106k.htm |
| 2014-12-08 | 6-K | 2014-12-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201412086k.htm |
| 2014-12-04 | 6-K | 2014-12-04 | STATEMENT ON ESTABLISHED PRODUCTS PORTFOLIO | gsk201412046k.htm |
| 2014-12-01 | 6-K | 2014-11-28 | TOTAL VOTING RIGHTS | gsk201412016k.htm |
| 2014-11-28 | 6-K | 2014-11-28 | PUBLICATION OF FINAL TERMS | gsk201411286k.htm |
| 2014-11-26 | 6-K | 2014-11-26 | REGULATORY UPDATE ON TRANSACTION WITH NOVARTIS | gsk201411266k.htm |
| 2014-11-24 | 6-K | 2014-11-24 | 6-K | d788516d6k.htm |
| 2014-11-24 | 6-K | 2014-11-24 | DIRECTOR/PDMR SHAREHOLDING | gsk201411246k2.htm |
| 2014-11-24 | 6-K | 2014-11-24 | PUBLICATION OF CIRCULAR AND NOTICE OF GM | gsk201411246k.htm |
| 2014-11-18 | 6-K | 2014-11-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201411186k.htm |
| 2014-11-14 | 6-K | 2014-11-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201411146k2.htm |
| 2014-11-14 | 6-K | 2014-11-14 | DIRECTOR/PDMR SHAREHOLDING- AMENDMENT | gsk201411146k1.htm |
| 2014-11-14 | 6-K | 2014-11-14 | DIRECTOR/PDMR SHAREHOLDING- AMENDMENT | gsk201411146k.htm |
| 2014-11-12 | 6-K | 2014-11-12 | BLOCKLISTING INTERIM REVIEW | gsk201411126k2.htm |
| 2014-11-12 | 6-K | 2014-11-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201411126k.htm |
| 2014-11-10 | 6-K | 2014-11-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201411106k.htm |
| 2014-11-07 | 6-K | 2014-11-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201411076k1.htm |
| 2014-11-07 | 6-K | 2014-11-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201411076k.htm |
| 2014-11-05 | 6-K | 2014-11-05 | REGULATORY SUBMISSIONS FOR MEPOLIZUMAB | gsk201411056k.htm |
| 2014-11-03 | 6-K | 2014-11-03 | TOTAL VOTING RIGHTS | gsk201411036k.htm |
| 2014-10-29 | 6-K | 2014-10-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201410296k.htm |
| 2014-10-27 | 6-K | 2014-10-27 | PUBLICATION OF SUPPLEMENTARY PROSPECTUS | gsk201410276k3.htm |
| 2014-10-27 | 6-K | 2014-10-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201410276k2.htm |
| 2014-10-27 | 6-K | 2014-10-27 | DIRECTOR/PDMR SHAREHOLDING | gsk201410276k.htm |
| 2014-10-24 | 6-K | 2014-10-24 | DIRECTOR/PDMR SHAREHOLDING | gsk201410246k.htm |
| 2014-10-23 | 6-K | 2014-10-23 | DIRECTOR/PDMR SHAREHOLDING | gsk201410236k.htm |
| 2014-10-22 | 6-K | 2014-10-22 | 3RD QUARTER RESULTS | gsk201410226k.htm |
| 2014-10-22 | 6-K | 2014-10-22 | RE DIRECTORATE | gsk201410226k1.htm |
| 2014-10-20 | 6-K | 2014-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201410206k3.htm |
| 2014-10-20 | 6-K | 2014-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201410206k2.htm |
| 2014-10-20 | 6-K | 2014-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201410206k1.htm |
| 2014-10-20 | 6-K | 2014-10-20 | DIRECTOR/PDMR SHAREHOLDING | gsk201410206k.htm |
| 2014-10-14 | 6-K | 2014-10-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201410146k3.htm |
| 2014-10-14 | 6-K | 2014-10-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201410146k2.htm |
| 2014-10-14 | 6-K | 2014-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201410146k.htm |
| 2014-10-14 | 6-K | 2014-10-13 | DIRECTOR/PDMR SHAREHOLDING | gsk201410136k.htm |
| 2014-10-10 | 6-K | 2014-10-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201410106k1.htm |
| 2014-10-10 | 6-K | 2014-10-09 | DIRECTORATE CHANGE | gsk201410106k.htm |
| 2014-10-07 | 6-K | 2014-10-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201410076k.htm |
| 2014-10-06 | 6-K | 2014-10-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201410066k1.htm |
| 2014-10-06 | 6-K | 2014-10-06 | DIRECTOR/PDMR SHAREHOLDING | gsk201410066k.htm |
| 2014-10-03 | 6-K | 2014-10-03 | DIRECTORATE CHANGE | gsk201410036k3.htm |
| 2014-10-03 | 6-K | 2014-10-03 | DIRECTOR/PDMR SHAREHOLDING | gsk201410036k2.htm |
| 2014-10-03 | 6-K | 2014-10-03 | DIRECTOR/PDMR SHAREHOLDING | gsk201410036k.htm |
| 2014-10-01 | 6-K | 2014-10-01 | DIRECTORATE CHANGE | gsk201410016k3.htm |
| 2014-10-01 | 6-K | 2014-10-01 | DIRECTOR/PDMR SHAREHOLDING | gsk201410016k2.htm |
| 2014-10-01 | 6-K | 2014-10-01 | TOTAL VOTING RIGHTS | gsk201410016k.htm |
| 2014-09-29 | 6-K | 2014-09-29 | DIRECTOR/PDMR SHAREHOLDING | gsk201409296k.htm |
| 2014-09-25 | 6-K | 2014-09-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201409256k3.htm |
| 2014-09-25 | 6-K | 2014-09-25 | DIRECTOR/PDMR SHAREHOLDING | gsk201409256k2.htm |
| 2014-09-25 | 6-K | 2014-09-25 | DIRECTORATE CHANGE | gsk201409256k.htm |
| 2014-09-19 | 6-K | 2014-09-19 | GSK CHINA INVESTIGATION OUTCOME | gsk201409196k.htm |
| 2014-09-16 | 6-K | 2014-09-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201409166k.htm |
| 2014-09-10 | 6-K | 2014-09-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201409106k.htm |
| 2014-09-08 | 6-K | 2014-09-08 | PUBLICATION POSITIVE STUDY RESULTS MEPOLIZUMAB | gsk201409086k.htm |
| 2014-09-03 | 6-K | 2014-09-03 | TRIUMEQ RECEIVES EU APPROVAL | gsk201409036k.htm |
| 2014-09-02 | 6-K | 2014-09-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201409026k.htm |
| 2014-09-02 | 6-K | 2014-09-02 | TOTAL VOTING RIGHTS | gsk201409016k.htm |
| 2014-08-22 | 6-K | 2014-08-22 | TRIUMEQ US APPROVAL | gsk201408226k.htm |
| 2014-08-18 | 6-K | 2014-08-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201408186k.htm |
| 2014-08-12 | 6-K | 2014-08-12 | DIRECTOR/PDMR SHAREHOLDING | gsk201408126k.htm |
| 2014-08-11 | 6-K | 2014-08-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201408116k.htm |
| 2014-08-08 | 6-K | 2014-08-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201408086k1.htm |
| 2014-08-08 | 6-K | 2014-08-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201408086k.htm |
| 2014-08-05 | 6-K | 2014-08-05 | DIRECTOR/PDMR SHAREHOLDING | gsk201408056k.htm |
| 2014-08-01 | 6-K | 2014-08-01 | TOTAL VOTING RIGHTS | gsk201408016k.htm |
| 2014-07-24 | 6-K | 2014-07-24 | DIRECTOR/PDMR SHAREHOLDING | gsk201407246k1.htm |
| 2014-07-24 | 6-K | 2014-07-24 | BLOCKLISTING INTERIM REVIEW | gsk201407246k.htm |
| 2014-07-23 | 6-K | 2014-07-23 | HALF YEARLY REPORT | gsk201407236k.htm |
| 2014-07-21 | 6-K | 2014-07-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201407216k3.htm |
| 2014-07-21 | 6-K | 2014-07-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201407216k2.htm |
| 2014-07-21 | 6-K | 2014-07-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201407216k1.htm |
| 2014-07-21 | 6-K | 2014-07-21 | DIRECTOR/PDMR SHAREHOLDING | gsk201407216k.htm |
| 2014-07-18 | 6-K | 2014-07-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201407186k2.htm |
| 2014-07-18 | 6-K | 2014-07-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201407186k1.htm |
| 2014-07-18 | 6-K | 2014-07-18 | DIRECTOR/PDMR SHAREHOLDING | gsk201407186k.htm |
| 2014-07-17 | 6-K | 2014-07-17 | MEK/BRAF COMBINATION PHASE III STUDY UPDATE | gsk201407176k1.htm |
| 2014-07-16 | 6-K | 2014-07-16 | DIRECTOR/PDMR SHAREHOLDING | gsk201407176k.htm |
| 2014-07-16 | 6-K | 2014-07-16 | START OF PHASE III STUDY - FF/UMEC/VI COMBINATION | gsk201407166k.htm |
| 2014-07-14 | 6-K | 2014-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201407146k1.htm |
| 2014-07-14 | 6-K | 2014-07-14 | DIRECTOR/PDMR SHAREHOLDING | gsk201407146k.htm |
| 2014-07-11 | 6-K | 2014-07-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201407116k3.htm |
| 2014-07-11 | 6-K | 2014-07-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201407116k2.htm |
| 2014-07-11 | 6-K | 2014-07-11 | DIRECTOR/PDMR SHAREHOLDING | gsk201407116k.htm |
| 2014-07-10 | 6-K | 2014-07-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201407106k3.htm |
| 2014-07-10 | 6-K | 2014-07-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201407106k2.htm |
| 2014-07-10 | 6-K | 2014-07-10 | DIRECTOR/PDMR SHAREHOLDING | gsk201407106k.htm |
| 2014-07-08 | 6-K | 2014-07-08 | DIRECTOR/PDMR SHAREHOLDING | gsk201407086k.htm |
| 2014-07-07 | 6-K | 2014-07-07 | DIRECTOR/PDMR SHAREHOLDING | gsk201407076k.htm |
| 2014-07-02 | 6-K | 2014-07-02 | DIRECTOR/PDMR SHAREHOLDING | gsk201407026k.htm |
| 2014-07-01 | 6-K | 2014-07-01 | TOTAL VOTING RIGHTS | gsk201407016k.htm |
| 2014-06-30 | 6-K | 2014-06-30 | DIRECTOR/PDMR SHAREHOLDING | gsk201406306k1.htm |
| 2014-06-30 | 6-K | 2014-06-30 | BREO ELLIPTA US REGULATORY SUBMISSION | gsk201406306k.htm |
| 2014-06-27 | 6-K | 2014-06-27 | TRIUMEQ RECEIVES POSITIVE CHMP OPINION | gsk201406276k.htm |
| 2014-06-24 | 6-K | 2014-06-24 | TRANSACTION IN OWN SHARES | gsk201406246k.htm |
| 2014-06-23 | 6-K | 2014-06-23 | DIRECTOR/PDMR SHAREHOLDING | gsk201406236k.htm |
| 2014-06-17 | 6-K | 2014-06-17 | TRANSACTION IN OWN SHARES | gsk201406176k.htm |